tirzepatide adolescent A Study of (LY3298176) Once Weekly in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities Efficacy and safety of tirzepatide

It works as a Glucagon-like peptide (GLP)-1 receptor agonist and Gastric Inhibitory Peptide (GIP) agonist to maximize similar benefits seen with other GLP-1 medications, such as semaglutide

Many individuals begin noticing appetite changes within the first few weeks of treatment

Calculate exactly what you need with our peptide cost calculator

Mounjaro vermindert de eetlust, zorgt voor een sneller en langduriger verzadigd gevoel en kan leiden tot aanzienlijk gewichtsverlies wanneer het wordt gecombineerd met een gezonde leefstijl

Quick Answer: Most patients experience noticeable appetite suppression within one to four weeks of starting tirzepatide, with effects becoming more pronounced as doses are gradually increased